Beryl A. Hatton

1.3k total citations
15 papers, 778 citations indexed

About

Beryl A. Hatton is a scholar working on Molecular Biology, Biotechnology and Oncology. According to data from OpenAlex, Beryl A. Hatton has authored 15 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Biotechnology and 3 papers in Oncology. Recurrent topics in Beryl A. Hatton's work include Hedgehog Signaling Pathway Studies (7 papers), Epigenetics and DNA Methylation (6 papers) and Microbial Inactivation Methods (4 papers). Beryl A. Hatton is often cited by papers focused on Hedgehog Signaling Pathway Studies (7 papers), Epigenetics and DNA Methylation (6 papers) and Microbial Inactivation Methods (4 papers). Beryl A. Hatton collaborates with scholars based in United States, South Africa and Spain. Beryl A. Hatton's co-authors include James M. Olson, Stacey Hansen, Joel I. Pritchard, Andrew R. Hallahan, Irwin D. Bernstein, Tom Russell, Jennifer Stoeck, M. Douglas Benson, Richard G. Ellenbogen and Sally Ditzler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Beryl A. Hatton

12 papers receiving 770 citations

Peers

Countries citing papers authored by Beryl A. Hatton

Since Specialization

Citations

This map shows the geographic impact of Beryl A. Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beryl A. Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beryl A. Hatton more than expected).

Fields of papers citing papers by Beryl A. Hatton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beryl A. Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beryl A. Hatton. The network helps show where Beryl A. Hatton may publish in the future.

Co-authorship network of co-authors of Beryl A. Hatton

This figure shows the co-authorship network connecting the top 25 collaborators of Beryl A. Hatton. A scholar is included among the top collaborators of Beryl A. Hatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beryl A. Hatton. Beryl A. Hatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Safety and Feasibility of Pulsed Electric Field Ablation for Early‐Stage Non‐Small Cell Lung Cancer Prior to Surgical Resection 2025 ·Journal of Surgical Oncology ·Marcelo F. Jiménez, Javier Flandes, Erik H.F.M. van der Heijden, Calvin S.H. Ng, (unknown), (unknown), (unknown), Roel L.J. Verhoeven, Rainbow W. H. Lau, (unknown), Beryl A. Hatton, (unknown), (unknown), William Krimsky	3
2	Airway Mucus Plugging in Chronic Bronchitis and the Impact of Bronchial Rheoplasty 2025 ·CHEST Journal ·William Krimsky, Joseph Mammarappallil, Victor Kim, (unknown), (unknown), Beryl A. Hatton, Frank C. Sciurba	0
3	The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer 2025 ·Journal of Bronchology & Interventional Pulmonology ·Michael A. Pritchett, Janani Reisenauer, Sebastián Fernández-Bussy, David M. DiBardino, Stephen J. Hunt, C. Kevin, Bradley B. Pua, (unknown), Beryl A. Hatton, (unknown), (unknown), William Krimsky	0
4	A quantitative method for assessing treatment-related changes within the airway mucosa in patients with chronic bronchitis 2024 ·Respiratory Medicine ·William Krimsky, Paul A. VanderLaan, (unknown), David W. Hunter, Beryl A. Hatton, (unknown), Victor Kim	0
5	697 Pulsed Electric Fields induces a stepwise activation of host anti-tumor immunity in patients with early-stage non-small cell lung cancer (NSCLC) 2023 ·SHILAP Revista de lepidopterología ·Marcelo F. Jiménez, (unknown), (unknown), Erik H.F.M. van der Heijden, Calvin S.H. Ng, Rainbow W. H. Lau, (unknown), Carlos Alberto Vanegas Prieto, Alberto Órfão, Roel L.J. Verhoeven, (unknown), Beryl A. Hatton, (unknown), Glòria Mas Martín, William Krimsky	5
6	702 Tertiary lymphoid structures (TLS) observed in non-small cell lung cancer (NSCLC) tumors treated with pulsed electric fields 2022 ·Regular and Young Investigator Award Abstracts ·(unknown), Paul A. VanderLaan, Marcelo F. Jiménez, (unknown), (unknown), Erik H.F.M. van der Heijden, Calvin S.H. Ng, (unknown), (unknown), (unknown), (unknown), (unknown), Beryl A. Hatton, William Krimsky	7
7	Abstract 620: Intratumoral microdosing via the CIVO® Platform reveals anti-tumor immune responses induced by the STING Agonist TAK-676 alone and in combination with chemotherapies 2022 ·Cancer Research ·Beryl A. Hatton, Marc Grenley, Sally Ditzler, Richard A. Klinghoffer, Allison Berger, Karim Malek, Richard C. Gregory, Neil Lineberry	1
8	Abstract 4136: Direct intratumoral microdosing via the CIVO® platform reveals anti-tumor immune responses induced by the SUMO inhibitor TAK-981 2019 ·Cancer Research ·Beryl A. Hatton, Marc Grenley, James Garnsey, Vaishali Shinde, Dennis Huszar, (unknown), Sally Ditzler, (unknown), Joyoti Dey, (unknown), Richard A. Klinghoffer	1
9	A Distinct Smoothened Mutation Causes Severe Cerebellar Developmental Defects and Medulloblastoma in a Novel Transgenic Mouse Model 2012 ·Molecular and Cellular Biology ·Joyoti Dey, Sally Ditzler, Sue E. Knoblaugh, Beryl A. Hatton, Janell M. Schelter, Michele A. Cleary, Brig Mecham, Lucy B. Rorke‐Adams, James M. Olson	35
10	Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model 2012 ·Proceedings of the National Academy of Sciences ·(unknown), Beryl A. Hatton, Elisabeth H. Villavicencio, Paritosh C. Khanna, Seth D. Friedman, Sally Ditzler, Barbara Pullar, Keith Robison, Kerry White, (unknown), Michael LeBlanc, Julie Randolph‐Habecker, Sue E. Knoblaugh, Stacey Hansen, Andrew Richards, Brandon J. Wainwright, Karen McGovern, James M. Olson	103
11	Notch signaling is not essential in sonic hedgehog-activated medulloblastoma 2010 ·Oncogene ·Beryl A. Hatton, Elisabeth H. Villavicencio, Joel I. Pritchard, Michael LeBlanc, Stacey Hansen, Michelle Ulrich, Sally Ditzler, Barbara Pullar, M R Stroud, James M. Olson	16
12	The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread 2008 ·Cancer Research ·Beryl A. Hatton, Elisabeth H. Villavicencio, Karen D. Tsuchiya, Joel I. Pritchard, Sally Ditzler, Barbara Pullar, Stacey Hansen, Sue E. Knoblaugh, Donghoon Lee, Charles G. Eberhart, Andrew R. Hallahan, James M. Olson	137
13	Nervous system cancer models: Medulloblastoma 2006 ·Drug Discovery Today Disease Models ·Beryl A. Hatton, Joel I. Pritchard, James M. Olson	3
14	N-myc Is an Essential Downstream Effector of Shh Signaling during both Normal and Neoplastic Cerebellar Growth 2006 ·Cancer Research ·Beryl A. Hatton, Paul S. Knoepfler, Anna Marie Kenney, David H. Rowitch, Ignacio Moreno de Alborán, James M. Olson, Robert N. Eisenman	128
15	The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas 2004 ·Cancer Research ·Andrew R. Hallahan, Joel I. Pritchard, Stacey Hansen, M. Douglas Benson, Jennifer Stoeck, Beryl A. Hatton, Tom Russell, Richard G. Ellenbogen, Irwin D. Bernstein, (unknown), James M. Olson	339

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact